# Evaluation of The Efficacy and Safety of Tixel Treatment for the Treatment of Facial and/or Scalp Actinic Keratoses

> **NCT04527653** · NA · COMPLETED · sponsor: **Novoxel Ltd.** · enrollment: 20 (actual)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DEVICE:** Tixel

## Key facts

- **NCT ID:** NCT04527653
- **Lead sponsor:** Novoxel Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-14
- **Primary completion:** 2021-04-19
- **Final completion:** 2021-04-19
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04527653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04527653, "Evaluation of The Efficacy and Safety of Tixel Treatment for the Treatment of Facial and/or Scalp Actinic Keratoses". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04527653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*